Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.1% in the 4th quarter, Holdings Channel reports. The fund owned 24,777 shares of the medical equipment provider’s stock after selling 36 shares during the period. Tocqueville Asset Management L.P.’s holdings in Intuitive Surgical were worth $12,933,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the company. Massachusetts Financial Services Co. MA acquired a new stake in Intuitive Surgical during the 3rd quarter valued at $558,807,000. Proficio Capital Partners LLC boosted its position in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares during the last quarter. FMR LLC grew its stake in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $313,769,000. Finally, Wilmington Savings Fund Society FSB lifted its stake in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after acquiring an additional 552,058 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ISRG. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Evercore ISI lifted their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $610.19.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $488.80 on Tuesday. The firm has a market capitalization of $174.10 billion, a PE ratio of 76.26, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business’s fifty day moving average price is $566.38 and its two-hundred day moving average price is $531.96.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.